209 related articles for article (PubMed ID: 20497911)
1. [Targeted treatment of rare connective tissue tumors and sarcomas].
Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
[TBL] [Abstract][Full Text] [Related]
2. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
3. [Molecular biology of soft-tissue sarcomas].
Coindre JM
Bull Cancer; 2010 Nov; 97(11):1337-45. PubMed ID: 21084242
[TBL] [Abstract][Full Text] [Related]
4. [Targeted therapy of sarcomas].
Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
[TBL] [Abstract][Full Text] [Related]
5. [Soft tissue sarcomas: clinical application of molecular biology].
Chetaille B; Laibe S; Choukeir N; Bertucci F
Rev Prat; 2013 Mar; 63(3):309-13. PubMed ID: 23687749
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy of soft tissue sarcomas.
Wardelmann E; Chemnitz JM; Wendtner CM
Onkologie; 2012; 35 Suppl 1():21-7. PubMed ID: 22286584
[TBL] [Abstract][Full Text] [Related]
7. Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
Penel N; Lebellec L; Blay JY; Robin YM
Crit Rev Oncol Hematol; 2020 Jun; 150():102960. PubMed ID: 32320927
[TBL] [Abstract][Full Text] [Related]
8. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
Sethi TK; Keedy VL
Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
[TBL] [Abstract][Full Text] [Related]
9. [Soft tissue sarcomas: update on molecular data].
Bui Nguyen Binh M; Collin F; Coindre JM
Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
[TBL] [Abstract][Full Text] [Related]
10. The clinical relevance of molecular genetics in soft tissue sarcomas.
Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
[TBL] [Abstract][Full Text] [Related]
11. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of sarcoma development.
Helman LJ; Meltzer P
Nat Rev Cancer; 2003 Sep; 3(9):685-94. PubMed ID: 12951587
[TBL] [Abstract][Full Text] [Related]
13. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
Genevay M; Gengler C; Guillou L
Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of human sarcomas: insights into sarcoma biology.
Baird K; Davis S; Antonescu CR; Harper UL; Walker RL; Chen Y; Glatfelter AA; Duray PH; Meltzer PS
Cancer Res; 2005 Oct; 65(20):9226-35. PubMed ID: 16230383
[TBL] [Abstract][Full Text] [Related]
15. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.
Komdeur R; Hoekstra HJ; Molenaar WM; Van Den Berg E; Zwart N; Pras E; Plaza-Menacho I; Hofstra RM; Van Der Graaf WT
Clin Cancer Res; 2003 Aug; 9(8):2926-32. PubMed ID: 12912938
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of soft tissue sarcomas based on the histological subtype].
Pápai Z
Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007
[TBL] [Abstract][Full Text] [Related]
18. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
19. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
[TBL] [Abstract][Full Text] [Related]
20. Genetics of rare mesenchymal tumors: implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa.
Rutkowski P; Przybył J; Świtaj T
Int J Biochem Cell Biol; 2014 Aug; 53():466-74. PubMed ID: 24704529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
